Ignite Creation Date:
2024-05-06 @ 9:58 AM
Last Modification Date:
2024-10-26 @ 12:22 PM
Study NCT ID:
NCT03125876
Status:
TERMINATED
Last Update Posted:
2021-03-24
First Post:
2017-04-09
Brief Title:
A Phase Ib Study of CT053PTSA in Relapsed Refractory Acute Myeloid Leukemia AML
Sponsor:
Sunshine Lake Pharma Co Ltd
Organization:
Sunshine Lake Pharma Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-11-13
Start Date Type:
ACTUAL
Primary Completion Date:
2019-08-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-08-19
Completion Date Type:
ACTUAL
First Submit Date:
2017-04-09
First Submit QC Date:
April 19 2017
Study First Post Date:
2017-04-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-22
Last Update Post Date:
2021-03-24
Last Update Post Date Type:
ACTUAL